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Abstract
Background: The recent advances in human genetics have recently provided new insights into
phenotypic variation and genome variability. Current forensic DNA techniques involve the search
for genetic similarities and differences between biological samples. Consequently the selection of
ideal genomic biomarkers for human identification is crucial in order to ensure the highest stability
and reproducibility of results.
Results: In the present study, we selected and validated 24 SNPs which are useful in human
identification in 1,040 unrelated samples originating from three different populations (Italian, Benin
Gulf and Mongolian). A Rigorous in silico selection of these markers provided a list of SNPs with
very constant frequencies across the populations tested as demonstrated by the Fst values.
Furthermore, these SNPs also showed a high specificity for the human genome (only 5 SNPs gave
positive results when amplified in non-human DNA).
Conclusion: Comparison between in silico and in vitro analysis showed that current SNPs databases
can efficiently improve and facilitate the selection of markers because most of the analyses
performed (Fst, r2, heterozigosity) in more than 1,000 samples confirmed available population data.
Background
Genetic variation in the human genome takes many
forms, ranging from large, microscopically visible chro-
mosome anomalies to single-nucleotide changes. In gen-
eral, forensic DNA analysis compares biological samples
searching for genetic similarities and differences by typing
a small number of genetic variable segments in each sam-
ple. Current methods used for performing forensic DNA
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analysis mainly focus on typing several STR (Short Tan-
dem Repeats) markers. STRs are smaller than VNTR
sequences and can easily discriminate between both
related and unrelated individuals [1]. At present, different
optimized multiplex assays are used to analyze unique
STRs loci located on different chromosomes with the
advantage of providing extremely low random match
probability (the probability of finding the same DNA pro-
file in a randomly selected, unrelated individual). The
only drawback in current forensic DNA typing systems is
that sometimes PCR amplicons are excessively large (rang-
ing from 100–400 bases in length). Sometimes DNA sam-
ples appear degraded into smaller fragments and
therefore, the higher molecular-weight STR loci can be
scarcely amplified so creating incomplete DNA profiles
with lower discrimination power [2]. The presence of
alternative types of DNA polymorphic markers in the
human genome i.e. Single Nucleotide Polymorphisms
(SNPs), abundantly spread along the chromosomes,
make it possible to develop different DNA profiling tech-
niques able to type smaller fragments of DNA (lower than
100 bp) compared to those detectable with STR markers
(100–400 bp). In addition, due to the biallelic nature of
SNPs, a size-based separation is not necessary so in turn
making a higher level of multiplexing and automation
possible compared to when using STRs. The latter are
extremely important in the implementation of large crim-
inal DNA databases [3,4]. Furthermore, SNPs have
smaller mutation rate (about 10-8) [5] compared to STRs
(ranging from 10-3 to 10-5) [6,7] and the number of chro-
mosomes which need typing to assess allele frequencies
for SNPs are lower compared to STRs because of the
smaller number of alleles. Nonetheless, several important
factors have to be considered for an accurate selection of
the SNPs to be used in forensic analysis. The first issue
concerns the correct evaluation of the frequency of each
SNP among the populations. STRs markers have many
alleles and each of them show worldwide low frequency
and consequently the random match probabilities are not
usually strongly dissimilar among the populations. Con-
versely, SNP markers can show very dissimilar frequencies
among different populations, causing a very large depend-
ence of the match probability on the population frequen-
cies used for the calculation [6]. An incorrect evaluation of
SNPs frequencies may give rise to ambiguity in genetic
results under specific conditions or in isolated popula-
tions. A second issue originates from the necessity to facil-
itate the stability and reproducibility of genetic typing for
which forensic SNPs should be exclusively found in the
human sequence and mapped in a single locus (single
copy SNP). Another important issue to consider for a cor-
rect SNPs selection follows the discovery reported in sev-
eral recent studies regarding the presence of an abundance
of submicroscopic copy number variation of DNA seg-
ments ranging from kilobases (kb) to megabases (Mb)
which include deletions, insertions, duplications and
complex multi-site variants in all humans and other
mammals [8]. These number variable regions (CNVRs)
cover 12% of the genome. It is thus preferable that SNPs
used in human identification are located outside the copy
number variable regions. In addition, the SNPs used in
forensic analysis should referentially not be located in
coding/regulatory regions in order to avoid the possibility
of obtaining unnecessary information concerning health
status and/or disease susceptibility or resistance of the
individual analyzed thus giving the courtroom the possi-
bility to reject DNA tests [9]. It follows that forensic mark-
ers should not be published as susceptibility/resistance/
prognostic factors in scientific publications. The above
mentioned issues highlight the importance of the availa-
bility of genetic databases to help facilitate SNPs selection.
In this work, we present a combination of in silico and in
vitro genetic analysis to validate and test a panel of 24
SNPs for human identification, selected on the basis of
very stringent criteria. A total of 24,960 genotypes of indi-
viduals originating from three different continents
(Europe, Africa and Asia) were analysed to assess allele
frequencies and the results were compared with current
available SNPs databases. The specificity of selected SNPs
for the human genome was tested by combining in silico
selection and in vitro testing of non-human DNA. In this
study, we provide a list of 24 SNPs specifically designed
for human identification and recommend an intensive
use of current genetic database which can strongly
improve the a priori selection of the SNPs because most
analyses performed (Fst, r2, heterozigosity) in our samples
confirmed in silico analysis.
Results
Selected SNPs are distributed across 13 autosomes and the
two sexual chromosomes. Six chromosomes contain
more than 1 SNP. The frequencies of the chosen SNPs are
reported in Table 1. Genotype frequencies observed for
the selected SNPs in 1,040 unrelated individuals showed
their high informative capacity thus confirming the data
reported in the HapMap database. The heterozygosity val-
ues calculated in the three populations considered in this
study range between 0.410 and 0.497, the mean value
being 0.473 with a standard deviation of 0.01. These latter
values are quite similar to those reported in the HapMap
database. In particular, the average heterozygosity
observed in the typed Italian samples was 0.460 com-
pared to the 0.480 calculated on the basis of genotype fre-
quencies reported for CEU samples in the HapMap
database. No differences were noted between the hetero-
zygosity observed in the Benin and Mongolian samples
(0.480 and 0.480 respectively) and those reported for YRI
and CHB in the HapMap database (0.486 and 0.486
respectively). While no differences in the mean heterozy-
gosity of the entire panel of SNPs were observed, signifi-BMC Genomics 2007, 8:457 http://www.biomedcentral.com/1471-2164/8/457
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cant differences in allele frequencies of a number of SNPs
compared to those reported in the HapMap database were
noted. We observed significant differences between the
Italian and CEU (CEPH- HapMap project) samples for
four SNPs: rs905213 (p = 0.001), rs1533800 (p = 0.009),
rs886528 (p = 0.047), rs154659 (0.028) (Table 1). It
should be mentioned that CEPH samples were collected
from people living in Utah with ancestry from northern
and western Europe collected in 1980 and it is unclear
how accurately these samples reflect the patterns of
genetic variation in people with northern and western
European ancestry. We also observed a highly significant
difference in allele frequency between the Benin and
Yoruba samples (HapMap Project) for the SNP rs3130315
(p = 2 × 10-5) and between the Mongolian and Han Chi-
nese samples (HapMap project) for two SNPs: rs9562080
(p = 0.047) and rs4116821 (7.36 × 10-11). Considering
that genetic markers may also show dissimilar allele fre-
quencies among populations due to differences in muta-
tion rates, neutrality or linkage disequilibrium with other
loci subjected to selection, the Fst  distribution of the
selected SNPs in these populations was calculated. For
each autosomal marker, the lower the Fst value among the
populations, the higher is the worldwide applicability of
that specific SNP for human identification. Fst  values
ranged between 0.001 and 0.143, while the mean value
observed for all the autosomal SNPs was 0.037 ± 0.047.
Calculation of Fst values on the HapMap data generated
similar results: Fst  values ranged between 0.0000 and
0.0792, while the mean value observed for all the auto-
somic SNPs is 0.028 ± 0.025. In order to ensure the inde-
pendence of markers, all the syntenic autosomal SNPs
selected were very far from each other, with a minimum
distance of 27 Mb observed between rs1506981 and
rs1533800 on chromosome 11 (Table 1). Linkage dise-
quilibrium (LD) decays with map distance along the chro-
mosome at a rate determined by the effective population
size and therefore should not be expected in our syntenic
SNPs. However, we assessed the independence of varia-
tion for all the selected SNPs by calculating pairwise LD
values reported as r2. Most of the selected autosomal SNPs
showed r2 values near zero: the average was 0.01 ± 0.02 in
Europeans; 0.02 ± 0.07 in Africans; 0.07 ± 0.09 in Asians.
The use of LD plotter software [10] revealed no significant
evidence of linkage disequilibrium (LD) between markers
mapped on chromosome Y (rs4116821, rs1421177 and
rs2032652) [11]. All the SNPs were selected to be specific
for a single locus in the human genome. The typing of the
Table 1: Chromosome localization, nucleotide position, allele variations, average heterozygosity and Fst values of the selected 
markers. Minor allele frequency (MAF) of HapMap data are reported in the brackets.
European 
Population
African 
Population
Asian 
Population
SNPs Chr Nucleotide 
position
Variation Hap map 
Heterozygo
sity
Minor all. 
frequency
Minor all. 
frequency
Minor all. 
frequency
Fst
rs1779866 1 61,194,420 C/G 0.497 0.43 (0.44) 0.47 (0.50) 0.45 (0.50) 0.0126
rs1922807 2 77,574,919 A/G 0.493 0.46 (0.50) 0.37 (0.40) 0.38 (0.46) 0.0318
rs2278741 2 121,465,927 C/G 0.470 0.27 (0.31) 0.37 (0.40) 0.40 (0.53) 0.1430
rs2962594 5 2,759,621 A/G 0.477 0.38 (037) 0.44 (0.43) 0.45 (0.37) 0.0333
rs905213 5 91,995,945 C/T 0.463 0.38 (0.61) 0.35 (0.35) 0.41 (0.36) 0.0000
rs11242909 6 422,065 C/T 0.536 0.33 (0.30) 0.38 (0.50) 0.39 (0.50) 0.0000
rs3130315 6 32,328,663 A/G 0.467 0.38 (0.38) 0.37 (0.67) 0.46 (0.50) 0.0634
rs7740233 6 150,965,880 C/T 0.477 0.43 (0.44) 0.45 (0.42) 0.44 (0.51) 0.0136
rs10866988 8 5,235,745 C/G 0.500 0.47 (0.46) 0.49 (0.50) 0.40 (0.43) 0.0127
rs1506981 11 6,735,647 A/G 0.487 0.55 (0.53) 0.33 (0.37) 0.34 (0.44) 0.0146
rs1533800 11 33,781,074 A/C 0.487 0.22 (0.49) 0.42 (0.45) 0.41 (0.42) 0.1278
rs1981752 12 16,430,035 C/T 0.487 0.33 (0.36) 0.44 (0.48) 0.49 (0.52) 0.0955
rs478347 12 128,915,904 G/T 0.510 0.49 (0.48) 0.46 (0.45) 0.42 (0.35) 0.0032
rs9562080 13 113,941,879 C/G 0.483 0.50 (0.39) 0.44 (0.45) 0.47 (0.61) 0.0034
rs8033863 15 99,857,192 C/G 0.407 0.37 (0.38) 0.36 (0.43) 0.40 (0.39) 0.0000
rs886528 16 3,751,557 C/T 0.500 0.38 (0.52) 0.40 (0.47) 0.45 (0.43) 0.0450
rs154659 16 88,194,838 C/T 0.467 0.16 (0.29) 0.49 (0.46) 0.34 (0.42) 0.1229
rs2317225 17 2,593,098 A/G 0.490 0.37 (0.38) 0.45 (0.52) 0.39 (0.48) 0.0029
rs11881170 19 62,864,113 A/C 0.497 0.39 (0.44) 0.41 (0.42) 0.35 (0.30) 0.0000
rs380011 21 14,542,669 C/T 0.487 0.39 (0.36) 0.48 (0.48) 0.45 (0.50) 0.0133
rs2267628 X 137,456,866 A/G - 0.49 (0.46) 0.03 (0.02) 0.21 (0.12) -
rs4116821 Y 20,531,728 C/G - 0.37 (0.46) 0.01 (0.19) 0.35 (0.00) -
rs1421177 Y 18,027,988 G/A - 0.00 0.00 0.00 -
rs2032652 Y 20,305,438 C/T - 0.13 (0.00) 0.00 (0.00) 0.46 (0.46) -BMC Genomics 2007, 8:457 http://www.biomedcentral.com/1471-2164/8/457
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SNPs in the DNA from the closest living relative of Homo
sapiens (Pan troglodytes) and Macaca fascicularis made it
possible to confirm in silico specificity (tested by Blast)
for 19 SNPs. We observed positive amplification for a sin-
gle marker in Macaca fascicularis and for five markers in
Pan troglodytes. SNP rs886528 was typed in Macaca fascic-
ularis DNA and SNPs rs1779866, rs905213, rs1506981,
rs8033863 and rs886528 were typed in Pan troglodytes
DNA. All TaqMan assays that provided interpretable sig-
nal in real-time PCR were re-sequenced to determine the
exact sequence homologies between the species. As
expected on the basis of in silico and in vitro results, the
random match probability using the entire 24 SNPs panel
was very similar in the three populations tested: 5.7 × 10-
11 in Europeans, 7.8 × 10-10 in Africans, 3.4 × 10-11. The
cumulative random match probability shown above indi-
cates that the likelihood that a specific profile occurs in
more than a single individual is less than 1 in
100,000,000,000.
Discussion
We carried out a study regarding the selection of a panel
of 24 SNPs for forensic analysis. We mainly focused on in
silico selection of SNPs to avoid unspecific non human
amplification and unbalanced allele frequencies among
the populations. Through in silico searches, we selected
SNPs located in only human-specific sequences. In vitro
analysis showed that only five SNPs gave positive results
when amplified in DNA from the closest living relative of
Homo sapiens (Pan troglodytes) and from Macaca fascicula-
ris. We would like to emphasise that this number is lower
than figures reported do date in other studies. The latter
demonstrates how useful it is to carefully select SNPs by
comparing genomic sequences of different species [12-
15]. We also excluded an interdependence of selected
markers (to both autosomes and Y chromosome) by cal-
culating the extention of LD (r2 values were not signifi-
cant).
When considering the average values (heterozygosity;
allele frequencies, Fst values, RMP) of the entire panel of
SNPs calculated on the HapMap data, we observed no sig-
nificant deviation. Thus, the availability of genetic data-
bases strongly facilitates SNPs selection as to their
informative capacity: a priori selection criteria were con-
firmed by the genotyping of our populations. In the
present study, we report SNPs showing very high hetero-
zygosity values: the mean was 0.473 ± 0.01. Although it is
possible to observe significant differences between allele
frequencies for specific SNPs, on average, the deviation in
allele frequencies of a panel of SNPs between "expected"
(HapMap) and "observed" (genotyping) seems not to be
significant. These results may be due to divergences
among the populations analyzed in this work and those
typed in HapMap, or from the limited size of samples ana-
lyzed in the HapMap project. In fact, the mean heterozy-
gosity calculated on the basis of genotype frequencies
reported in the HapMap database was quite similar to the
one calculated in this work (0.484 ± 0.04). there is a sim-
ilar situation regarding differences in Fst values. Accord-
ingly, the differences in random match probabilities
calculated on the basis of both observed and expected fre-
quencies are not relevant. In particular, the RMP arising
from data (CEU) reported in HapMap was 2.4 × 10-11
quite similar to the one calculated in this work 5.7 × 10-11
(Italian). The same situation is evident in African and
Asian populations where the RMP observed were similar
to those calculated with the HapMap data (in the brack-
ets): 7.8 × 10-10 (8.1 × 10-10) in Africans; 3.4 × 10-11 (2.4 ×
10-10). These data suggest that the main effort in develop-
ing a SNP panel for forensic purposes should be mainly
directed towards the selection of universal forensic SNPs
to be used and on typing admixed populations in order to
confirm the worldwide balance of allele frequencies of
SNPs. The efficiency of the programs used for the align-
ment of genome sequences can strongly improve the proc-
ess of selection of human-specific SNPs.
Conclusion
In this paper, we selected and validated 24 SNPs useful for
human identification. To generate allele frequencies, we
used the Real-Time PCR. However, it should be noted that
this technique cannot produce a multiplexing of the PCR
and therefore, it could be of only limited use in forensic
practice. We showed that current SNPs databases can effi-
ciently improve and facilitate the selection of markers
since most of the reported frequencies have been con-
firmed in recent works. The most important aspect of
SNPs selection criteria is the choice of those SNPs with
low Fst among populations and with a single locus loca-
tion exclusively in the human genome. Rigorous marker
selection criteria have been fundamental for performing a
SNP-base human identification. Compared to previous
reported SNPs selection [16], here we report a much
higher percentage of SNPs (80%) specific for the human
genome. We also recommend selecting markers located
outside regions containing copy number variations. So
far, the availability of several maps of copy number varia-
tions in the human genome has shown that we are genet-
ically more diverse than expected and that our genome
appears to be even more amorphous and changeable than
expected. Consequently, the selection of SNPs for human
identification needs to consider all these variables in order
to ensure the highest stability and reproducibility of
results. During the final phases of this work, a CNV map
of the human genome was published through the study of
270 individuals from four of the populations typed in the
HapMap project. Three new segmental duplications were
observed within the RP11-420I5, RP11-530H6 and RP11-
469G12 clones which contain respectively selected mark-BMC Genomics 2007, 8:457 http://www.biomedcentral.com/1471-2164/8/457
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ers rs478347, rs8033863 and rs2317225. It is important
to underline, however, that forensic markers (WVA and
FGA) in current use are also located in CNV regions but no
genotyping errors have been reported to date and today
we do not know how many genomic regions may have
CNVs because the variability of the human genome is
much higher than previously supposed [17] and new CNV
regions are constantly being reported. Despite their
informative capacity and the absence of typing errors
observed in this work, the use of the SNPs rs478347,
rs8033863 and rs2317225 as markers for forensic pur-
poses should be considered with caution due to the fact
that typing errors arising from the complexity of the sur-
rounding genomic regions cannot be totally excluded.
Methods
Samples and DNA extraction
A total of 1,040 samples from Italy, the Benin gulf and
Mongolia were collected. The QIAamp DNA Blood Mini
Kit (QIAGEN Inc., Valencia, CA) was used to extract
genomic DNA from whole blood. DNA concentration was
determined by real-time PCR using the Quantifiler™
Human DNA Quantification Kit (Applied Biosystems).
Selection Criteria
A number of selection criteria were used to identify the
SNPs considered in this work (Table 1):
(i) SNPs location outside coding regions; not published as
resistance/susceptibility allele;
(ii) average minimal allele frequency (MAF) reported in
population databases of at least 0.4 by searching in popu-
lation databases [18].
(iii) SNPs location in a single locus in the human genome;
(iv) SNPs specificity for the predicted locus evaluated by
comparison of the sequences flanking the selected mark-
ers to those available in the Genebank database. A heuris-
tic search using the Genome BLAST (blastn) option was
performed using default parameters. BLAST (Basic Local
Alignment Search Tool) is a sequence similarity search
program that finds matches between a tag sequence and
human and non human sequences available in databases
[19]. SNPs whose surrounding sequence was found in dif-
ferent sites other than the one predicted, or which showed
too much similarity to sequences belonging to other spe-
cies' genomes, were not considered candidate markers for
human identification.
(v) examination of the flanking regions of the SNPs to
ensure that regions surrounding the polymorphic site
contained no additional variations. For two selected SNPs
(rs1922807 and rs886528), potential interfering addi-
tional polymorphisms at a distance of 46 bp upstream
and 40 bp downstream respectively were present but they
are not relevant in most genetic typing;
(vi) SNPs location outside the copy number variation
regions by search in the Database of Genomic Variants
[20]. In the final phase of this work, novel CNVs were
published encompassing regions involving three selected
SNPs rs478347; rs8033863; rs2317225 [8]. The three seg-
mental duplications within the RP11-420I5, RP11-530H6
and rp11-469g12. clones contain respectively SNPs
rs478347, rs8033863 and rs2317225.
Genotyping
Genotyping was performed by TaqMan assays (Applied
Biosystems). Primers and probe sequences of each Taq-
man assay are listed in Table 2. The average size of the
amplicons was 77 bp. Reactions were run in an AB7500
(Applied Biosystems) and interpreted using Sequence
Detection System (SDS) 2.1 software. Each plate con-
tained three positive controls (samples previously con-
firmed by direct sequencing as heterozygous and both
homozygous) and two negative controls. No departure
from the Hardy-Weinberg equilibrium was detected. Gen-
otype assessment for each SNP was confirmed by post-
genotyping direct re-sequencing of 50 random samples.
Statistical analysis
All the statistical analyses of forensic data were performed
as described by Brenner [9] and using DNAVIEW™ 27.19.
Statistical independence of selected markers was assessed
by calculating linkage disequilibrium (LD) as r2 [10] using
LDplotter software. Inter-population variability in allele
frequencies was assessed by calculating Fst for each marker
[21] To test the null hypothesis of no differences in allele
frequencies between the HapMap and typed populations,
the frequency distribution of alleles was analysed for our
samples as well as for the HapMap samples, using X2 test.
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Table 2: Primers and probes sequences of the SNPs tested.
SNP name PRIMER Forward PRIMER Reverse PROBE 1 PROBE 2
rs1779866 5'-
GGGATTAACTTTGCAAATGGA
ATTAAAGGA-3'
5'-
CCCTTTTAAGGACACTTTTG
ATTGCTT-3'
5'-CATAATCGAAGATCCTC-3' 5'-CATAATCCAAGATCCTC-3'
rs1922807 5'-
CATAGTCCCATAAGAATATGC
AGCATGT-3'
5'-
GTTGTAAGAAAACATATTAA
AAGCGGTACCA-3'
5'-
CAATAGATGATTCAATAATTT
-3'
5'-
AATAGATGATTCAGTAATTT-
3'
rs2278741 5'-
CCGTGTTTACAGTGTTTGCAT
GT-3'
5'-
AGCAGCCCCGAGGTATTTAG
A-3'
5'-
CCTGAAAAGAACACTTGTT-
3'
5'-CTGAAAAGAAGACTTGTT-
3'
rs2962594 5'-
GTCTTCCCCTCCCTTCTTTGT
C-3'
5'-
GAAGTGTTATCAAAATACAC
CTTGGAAATATCA-3'
5'-ACATGGTCAGCACTGG-3' 5'-CATGGTCAGCGCTGG-3'
rs905213 5'-
GGCTGATAACGTAACCCGAA
CT-3'
5'-
ATGAAGATCGGTGGCGGAA
AT-3'
5'-
CAATTTAATAAGTCTGAAAG
AC-3'
5'-
AATTTAATAAGTCTAAAAGA
C-3'
rs11242909 5'-
TGCCATCAAGTATATTTTGTG
TGATATCAACT-3'
5'-
CCCCAAAAAAAATGTTTGCT
AGGGAAA-3'
5'-
AAAAGAAAGCTAGTGGTGCT
A-3'
5'-
AAAAGAAAGCTAATGGTGCT
A-3'
rs3130315 5'-
AGCACTAGAGCTGCAAAGATA
TTGG-3'
5'-
GTCCCTTCTGAAACCTTACA
CATCA-3'
5'-
CATCTCACTCTCTAACCAA-3'
5'-CTCACTCTCCAACCAA-3'
rs7740233 5'-
GAGAGCCCCTTCTGCTTGTTT
-3'
5'-
AGCTCCTTGCTATTCTCAAT
TCTTATAAAACTC-3'
5'-CCTTTGTCTCAGGTCCTA-
3'
5'-CCTTTGTCTCAAGTCCTA-
3'
rs10866988 5'-
GCATCGGAAGCCATATTTTGT
GT-3'
5'-
ATTGTTTGACTCTTTTGGCC
GTTTT-3'
5'-CTTCTCCCAAGGCCA-3' 5'-CTTCTCCGAAGGCCA-3'
rs1506981 5'-
TCGGCTATGGAGGCCTATAA
GAG-3'
5'-
CAAAGATGCCTTGAGTTTTT
ATGTGATTTAGA-3'
5'-CCACCAGGTTTCA-3' 5'-CCACCGGGTTTCA-3'
rs1533800 5'-CCTGAGGAGGCAGTGTGG-
3'
5'-
AGACTAGGTCAGCAGGAAC
TCA-3'
5'-CAGATCCCAGATCTAGT-3' 5'-CAGATCCCAGCTCTAGT-3'
rs1981752 5'-
CTGCAAATGCTAATTGATAGA
TCAGCAA-3'
5'-
GGTAGAAAAGACGCAAAACT
CCAAA-3'
5'-
AAACTGTATGTGTTAAAAG-3'
5'-
AAACTGTATGTATTAAAAG-3'
rs478347 5'-
CCCATCTTTAGAGGGCCTGAA
A-3'
5'-
GCAGAAAGGAGCTGGAATT
CAAGTA-3'
5'-TCCACCAGTGGCATAG-3' 5'-ATCCACCAGTTGCATAG-3'
rs9562080 5'-
CCACCATTGATCTCTGAGCAT
CTC-3'
5'-AGGGTGTGGGCGGTG 5'-TGGCTGGGCCCCT-3' 5'-TGGCTGGGCGCCT-3'
rs8033863 5'-
GGAAGGAGTTGGCTAATACAA
TGCT-3'
5'-
CCAGGGCTCTAACACATATT
TTAAAAATCA-3'
5'-ACAGCGCTGCCACC-3' 5'-ACAGCCCTGCCACC-3'
rs886528 5'-
GAGGTTGGTCAAGAGTCTGTA
TCC-3'
5'-
CAGGCGCACCAAGAACATG-
3'
5'-ATTTCCATCAGAGCCCA-3' 5'-TTTCCATCAAAGCCCA-3'
rs154659 5'-
CCCCTCCTGACCTCGAATTAG
A-3'
5'-
CACATCCAGGCAGGTCATAC
C-3'
5'-CAGGCTATTCTCGGCAAG-
3'
5'-CAGGCTATTCTCAGCAAG-
3'
rs2317225 5'-
TCACCCAAGTCCAAGCCAAA
A-3'
5'-
AGATGACAGTCAGGAGCCT
ACT-3'
5'-CTTCTGGTGTACCATTG-3' 5'-TCTGGTGTGCCATTG-3'
rs11881170 5'-
TGTTGACTAGAGGCTGTGAG-
3'
5'-TCATGCCCAC 
ACTATGTCTA-3'
5'-
TTGAGCCTTCCTTACTAGTT
ACTA-3'
5'-
TTGAGCCTTCATTACTAGTT
ACTA-3'
rs380011 5'-
TGAGGAATGAGTTTATGTCCA
TTGAGTT-3'
5'-
CCACCCATAGCCCTCTGATT
C-3'
5'-CAGGTAAGAATAGGATTT-
3'
5'-CAGGTAAGAATAAGATTT-
3'
rs2267628 5'-
TCTTGGGGAAGGAGTGTTGT-
3'
5'-
TCAATGTGAGCGCTAAGACT
-3'
5'-
TTCATGAATAGATGATGCAA
CT-3'
5'-
TTCATGAATAAATGATGCAA
CTT-3'
rs4116821 5'-
CCATTATGCCTTTCTTTGAG-3'
5'-
TTATGTACAAAAATCTCATCT
CTCACTTTG-3'
5'-
GAGCTACGAGATGTAAAAGG
GA-3'
5'-
GAGCTACCAGATGTAAAAGG
GA-3'
rs1421177 5'-
TTGCCCTGTATGCCTACAAC-
3'
5'-
TTGCCAGAGACTAGAAAGAA
-3'
5'-
TTAGCTAACTCAAAACTCAC
AG-3'
5'-
TTAGCTAACTCAGAACTCAC
AG-3'
rs2032652 5'-
TTGGCCCAACACTGTTGCCA-
3'
5'-
TTTGCTGGTGATCCTGGACC
-3'
5'-
TATGTACAAAAATCTTATCTC
TCACT-3'
5'-
TATGTACAAAAATCTCATCT
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